Sino Biopharmaceutical | 1177 - Ebit



金融业
股票价格
CNY
资产
CNY 74.89B
现金及等价物
CNY 3.38B
销售成本
CNY 3.08B
流动资产
CNY 33.82B
流动负债
CNY 24.85B
债务
CNY 9.71B
股息收益率
CNY 1.35
EBIT
CNY 5.18B
EBITDA
CNY 2.59B
员工
CNY 25.81K
EPS每股收益
CNY -0.06
股本和储备
CNY 34B
销售毛利
CNY 10.5B
债务利息支出
CNY 76.87M
贷款资金
CNY 3.08B
市值
CNY 95.08B
净收入
CNY 3.39B
营业费用
CNY 12.39B
营业利润
CNY 5.18B
普通股股本
CNY 17.89B
PE价格收益
17.03
税前利润
CNY 1.81B
销售收入
CNY 14.26B
销售和管理费用
CNY 7.54B
股票
CNY 1.84B
贸易债权人
CNY 2.82B
应收帐款人
CNY 8.45B


Ebit 更改 日
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.01M 175K 2026-03
Avita Medical AUD -10.39M 1.72M 2025-12
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Dianthus Therapeutics USD -46.53M 23.01M 2026-03
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
IQVIA Holdings USD 2.6B 2.03B 2026-06
Jiangsu Hengrui CNY 2.56B 302M 2026-03
Moderna USD -1.39B 531M 2026-03
Organon & Co USD 324M 351M 2026-03
Revvity USD 82.77M 63.06M 2026-03
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Tectonic Therapeutic USD -27.3M 5.78M 2026-03
Viatris USD -20.2M 137.3M 2026-03
Xeris Pharmaceuticals USD 9.12M 7.65M 2026-03